NEW YORK, July 7, 2011 /PRNewswire/ --

Reportlinker.com announces that a new market research report is available in its catalogue:

Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011

http://www.reportlinker.com/p0567402/Benign-Prostatic-Hyperplasia-Global-Clinical-Trials-Review-Q2-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, "Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011" provides data on the Benign Prostatic Hyperplasia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Benign Prostatic Hyperplasia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Benign Prostatic Hyperplasia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

- Obtain discontinued trial listing for trials across the globe

- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 6

Introduction 7

Benign Prostatic Hyperplasia 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by BRIC Nations 16

Clinical Trials by Phase 17

In Progress Trials by Phase 18

Clinical Trials by Trial Status 19

Unaccomplished Trials of Benign Prostatic Hyperplasia 20

Subjects Recruited Over a Period of Time 23

Prominent Sponsors 24

Top Companies Participating in Benign Prostatic Hyperplasia Therapeutics Clinical Trials 26

Prominent Drug Comparison 28

Clinical Trial Profiles 29

Clinical Trial Overview of Top Companies 29

GlaxoSmithKline plc 29

Clinical Trial Overview of GlaxoSmithKline plc 29

Eli Lilly and Company 31

Clinical Trial Overview of Eli Lilly and Company 31

Sanofi 32

Clinical Trial Overview of Sanofi 32

Astellas Pharma Inc. 33

Clinical Trial Overview of Astellas Pharma Inc. 33

Health Ever Bio-Tech Co., Ltd. 34

Clinical Trial Overview of Health Ever Bio-Tech Co., Ltd. 34

Watson Pharmaceuticals, Inc. 35

Clinical Trial Overview of Watson Pharmaceuticals, Inc. 35

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

Nymox Pharmaceutical Corporation 37

Clinical Trial Overview of Nymox Pharmaceutical Corporation 37

AEterna Zentaris Inc. 38

Clinical Trial Overview of AEterna Zentaris Inc. 38

Allergan, Inc. 39

Clinical Trial Overview of Allergan, Inc. 39

QLT Inc. 40

Clinical Trial Overview of QLT Inc. 40

American Medical Systems Holdings, Inc. 41

Clinical Trial Overview of American Medical Systems Holdings, Inc. 41

Light Sciences Oncology, Inc. 42

Clinical Trial Overview of Light Sciences Oncology, Inc. 42

Bayer AG 43

Clinical Trial Overview of Bayer AG 43

Threshold Pharmaceuticals, Inc. 44

Clinical Trial Overview of Threshold Pharmaceuticals, Inc. 44

Spectrum Pharmaceuticals, Inc. 45

Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 45

Actavis, Inc. 46

Clinical Trial Overview of Actavis, Inc. 46

HANDOK Pharmaceuticals Co., Ltd. 47

Clinical Trial Overview of HANDOK Pharmaceuticals Co., Ltd. 47

Ferring Pharmaceuticals 48

Clinical Trial Overview of Ferring Pharmaceuticals 48

Sun Pharmaceutical Industries Limited 49

Clinical Trial Overview of Sun Pharmaceutical Industries Limited 49

Clinical Trial Overview of Top Universities / Institutes / Hospitals 50

Samsung Medical Center 50

Clinical Trial Overview of Samsung Medical Center 50

The National Institute of Diabetes and Digestive and Kidney Diseases 51

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 51

Hospital Authority 52

Clinical Trial Overview of Hospital Authority 52

Seoul National University Hospital 53

Clinical Trial Overview of Seoul National University Hospital 53

Assistance Publique - Hopitaux de Paris 54

Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 54

The International Kidney Stone Institute 55

Clinical Trial Overview of The International Kidney Stone Institute 55

The University of Tokyo Hospital 56

Clinical Trial Overview of The University of Tokyo Hospital 56

Erasmus MC 57

Clinical Trial Overview of Erasmus MC 57

University of California, San Francisco 58

Clinical Trial Overview of University of California, San Francisco 58

University of California, Irvine 59

Clinical Trial Overview of University of California, Irvine 59

Northwestern University 60

Clinical Trial Overview of Northwestern University 60

University of Alberta 61

Clinical Trial Overview of University of Alberta 61

Hospices Civils de Lyon 62

Clinical Trial Overview of Hospices Civils de Lyon 62

University of Washington 63

Clinical Trial Overview of University of Washington 63

University of Missouri 64

Clinical Trial Overview of University of Missouri 64

Southwest Hospital, China 65

Clinical Trial Overview of Southwest Hospital, China 65

Weill Cornell Medical College 66

Clinical Trial Overview of Weill Cornell Medical College 66

Chinese University of Hong Kong 67

Clinical Trial Overview of Chinese University of Hong Kong 67

Queen's University 68

Clinical Trial Overview of Queen's University 68

Lawson Health Research Institute 69

Clinical Trial Overview of Lawson Health Research Institute 69

Appendix 70

Abbreviations 70

Definitions 70

Research Methodology 71

Secondary Research 72

About GlobalData 72

Contact Us 73

Disclaimer 73

Source 73

List of Tables

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Zone, 2011* 8

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 11

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, North America, Top Countries, 2011* 13

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011* 14

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 15

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, BRIC Countries, 2011* 16

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Phase, 2011* 17

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 18

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19

Benign Prostatic Hyperplasia Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 20

Benign Prostatic Hyperplasia Therapeutics Market, Global, Terminated Clinical Trials, 2011* 21

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 25

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 27

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 28

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 29

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011* 31

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011* 32

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2011* 33

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Ever Bio-Tech Co., Ltd., 2011* 34

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Watson Pharmaceuticals, Inc., 2011* 35

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 36

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nymox Pharmaceutical Corporation, 2011* 37

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2011* 38

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2011* 39

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2011* 40

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by American Medical Systems Holdings, Inc., 2011* 41

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2011* 42

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2011* 43

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Threshold Pharmaceuticals, Inc., 2011* 44

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2011* 45

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis, Inc., 2011* 46

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by HANDOK Pharmaceuticals Co., Ltd., 2011* 47

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, 2011* 48

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2011* 49

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2011* 50

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011* 51

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2011* 52

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2011* 53

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2011* 54

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The International Kidney Stone Institute, 2011* 55

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2011* 56

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2011* 57

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011* 58

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2011* 59

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2011* 60

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2011* 61

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2011* 62

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 63

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2011* 64

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Hospital, China, 2011* 65

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2011* 66

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2011* 67

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2011* 68

Benign Prostatic Hyperplasia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2011* 69

List of Figures

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 8

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011* 14

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 15

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, BRIC Countries (%), 2011* 16

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 17

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 18

Benign Prostatic Hyperplasia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 23

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 24

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 26

Benign Prostatic Hyperplasia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 28

GlobalData Methodology 72

Companies Mentioned

To order this report:

Drug Discovery and Development Industry: Benign Prostatic Hyperplasia Global Clinical Trials Review, Q2, 2011

Drug Discovery and Development Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com